Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bacomind is a patented, standardized, full-spectrum botanical extract derived from Bacopa monnieri (Brahmi), developed by Natural Remedies. It is marketed as a dietary supplement and nutraceutical ingredient to support cognitive health, memory, learning, attention, and focus across both adult and pediatric populations. Standardized to contain nine bioactive compounds (including bacosides, bacopasaponins, and flavonoids), Bacomind is believed to support neuronal communication by enhancing neurotransmitter synthesis and promoting dendritic branching. It has been evaluated in multiple clinical trials for cognitive longevity, memory improvement in elderly individuals, and cognitive support in children with learning difficulties or ADHD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bacomind.